
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+16
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global mRNA medicines and vaccines company with enabling technologies: (i) LUNAR lipid-mediated delivery, (ii) STARR mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed Kostaive, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus pipeline includes RNA therapeutic candidates to potentially...
Mrna,lipid-mediated delivery,rare diseases,otc deficiency,cystic fibrosis,vaccines,therapeutics,hbv,coronavirus,covid-19,lipids,lunar,starr,innovation,discovery,leadership,partnerships,rna,development,mrna medicine,and glycogen storage disease
Arcturus therapeutics operates in the Biotechnology research industry.
Arcturus therapeutics's revenue is 101m - 500m
Arcturus therapeutics has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.